Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q2 2026 (June 30)4holders
0new positions
0sold out
$10.28avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($5K), PNC Financial Services Group, Inc. ($3K) and GAMMA Investing LLC ($2K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 16 shares bought and 109 shares sold, net −93 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Rhumbline Advisers | 0.00% | No change | 456 | $5K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -24.6% | 335 | $3K |
| GAMMA Investing LLC | 0.00% | No change | 182 | $2K |
| IMA Advisory Services, Inc. | 0.00% | Add +57.1% | 44 | $474 |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.